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Abstract. Six patients presented with musculoskele- 
tal pain resulting from destructive bone lesions. 
These patients were ultimately shown to have met- 
astatic pheochromocytoma. None of the cases ex- 
hibited typical symptoms of metastatic pheochro- 
mocytoma, nor was it suspected at the time of pre- 
sentation. In three patients, hypertension caused 
pheochromocytoma to be considered as a diagno- 
sis. The three remaining patients, all of whom had 
documented hypertension in the past, underwent 
bone biopsy. Two of these patients became mark- 
edly hypertensive in the postoperative period. 
Malignant pheochromocytoma may present with 
metastatic skeletal disease in some patients in 
whom the presence of hypertension as well as a 
carefully elicited history may suggest the diagnosis. 
In such patients, the possibility of pheochromocy- 
toma should be taken into account, as biopsy may 
trigger a hypertensive crisis in patients not under 
adrenergic blockade. 
Key words: Pheochromocytoma - Metastasis in 
bone - Bone biopsy under adrenergic blockade 
for approximately 0.1% of all patients with dia- 
stolic hypertension [9]. Other physical findings in- 
clude tachycardia, sweating, and pallor. 
Review of 56 patients with metastatic pheo- 
chromocytoma yielded six patients whose present- 
ing symptom was musculoskeletal pain secondary 
to destructive bone lesions, all later determined to 
be pheochromocytoma bone metastases. Although 
malignant pheochromocytoma will be diagnosed 
in very few cases of destructive bone lesions from 
an unknown cause, this diagnosis must be consid- 
ered because of the potentially lethal side effects 
of bone biopsy in patients not under adrenergic 
blockade. 
Material and methods 
We reviewed medical records of 56 patients with metastatic 
pheochromocytoma evaluated at the University of Michigan 
from 1980 to 1985. Six patients presented with musculoskeletal 
pain. All radiographic and scintigraphic studies available on 
these patients were reviewed. Plasma catecholamines were de- 
termined by radioenzymatic assay on samples drawn through 
an indwelling needle in resting, supine, and fasting conditions 
[13]. Iodine-131-MIBG scintigraphy was performed using 
0.5 mCi t3XI-MIBG as previously described [16]. 
Pheochromocytoma is a rare catecholamine-releas- 
ing tumor which is benign in approximately 90% 
of cases [4, 7, 11]. This tumor, even when widely 
metastatic, typically presents with symptoms such 
as headache, dizziness, flushing, and palpitations 
[4, 7, 11] that are related to increased circulating 
catecholamines. Hypertension, either episodic or 
sustained, is present in over 90% of pheochromo- 
cytoma patients [8]. Pheochromocytoma accounts 
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Results 
The findings in the six cases are summarized in 
Table 1. The patient group consisted of five men 
and one woman, 13 to 56 years of age. In all cases 
the diagnosis was confirmed by elevated catechol- 
amine levels. On initial history, none of the pa- 
tients complained of symptoms typically associated 
with pheochromocytoma (i.e., headache, sweating, 
palpitation, flushing, and dizziness). In retrospect 
three patients had experienced symptoms that were 
probably related to hypercatecholaminemia. Four 
patients were hypertensive when examined. Blood 
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Patient Age Sex Complaint History and physical 
(years) findings at presentation 
Radiographic 
findings 
Plasma catecholamine levels 
Norepinephrine epinephrine 
(pg/ml) (pg/ml) 
[nl < 500] [nl < 100] 
1 15 M Back pain after BP 180/130 
minor football Developed sweating, 
injury pallor, lightheadness 
after injury 
2 36 F Left hip pain BP I50/100 
Headache diagnosed as 
migraine. Hypertensive 
episodes during pregnancy 
3 53 M Right hip pain Four-year history of 
hypertension. Symptoms 
of pheochromocytoma in 
retrospect 
4 13 M Back pain and BP 180/120 
abnormal gait 
5 30 M Back pain BP 250/140 
Microscopic hematuria 
6 56 M Right shoulder Long-term difficulty 
and left thigh controlling hypertension 
pain 
Absent right 1733 194 
T6 pedicle 
Expansile lesion, 8156 121 
left pelvis 
Destructive lesion, 1978 2090 
right ilium 




Destructive 5922 235 
lesion T8 
Permeative lesions 1477 654 
in right humerus 
and left femur 
pressure readings were not available on the remain- 
ing two patients, but  both had histories of hyper- 
tension. 
Three patients presented with back pain, two 
with hip pain, and one with shoulder and thigh 
pain. Radiographic abnormalities were present in 
all six patients. Findings of bone destruction 
ranged from lytic lesions mixed with reactive scle- 
rosis (Fig. 1, patient 2) to purely permeative lytic 
lesions (Fig. 2, patient 6). Three patients presented 
with back pain referable to spinal lesions (Fig. 3, 
patient 5). 
In three cases, hypertension suggested the diag- 
nosis of pheochromocytoma,  but the three remain- 
ing patients underwent bone biopsy despite past 
documented hypertension. Two of these patients 
became markedly hypertensive in the postoperative 
period, with systolic blood pressures of  over 
200 m m  Hg. All three biopsies were misinterpreted 
initially and were only read correctly upon review. 
In two cases (patients 2 and 3), the initial biopsy 
interpretation was anaplastic small cell tumor. In 
patient 6, the biopsy was initially interpreted as 
transitional cell carcinoma. 
In all six patients, 131I-MIBG scans were posi- 
tive (i.e., demonstrated at least one abnormal focus 
of radiopharmaceutical uptake). A focus of 13~I- 
MIBG uptake corresponding to the symptomatic 
bone lesions was demonstrated in five of six cases 
(all but patient 5). 
Discussion 
Metastatic pheochromocytoma may present with 
musculoskeletal pain from bone metastases. This 
is not  surprising since bone is the most  common 
site of metastasis in this disease [5, 6, 12, 15]. We 
have recently reviewed the radiographic appear- 
ance of  bone metastases from pheochromocytoma 
[5]. Radiographic findings were found to vary, 
ranging from lytic-permeative to expansile-geo- 
graphic (with or without reactive sclerosis). The 
bone lesions in this series show a similar spectrum 
of radiographic findings, from lytic permeative 
(patient 6) to expansile-geographic mixed with 
reactive sclerosis (patient 2). 
Reasons for the lack of obvious symptoms re- 
lated to hypercatecholaminemia are unclear. In 
three patients, these symptoms were present, but 
their significance was not  appreciated until after 
the diagnosis was made. 
Although only a very small number  of patients 
who present with destructive bone lesions from an 
unknown cause will be shown to have pheochro- 
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Fig, 1. Expansile mixed lyric and 
sclerotic pheochromocytoma 
metastasis involving the left pelvis 
of a 36-year-old woman 
(patient 2) who presented with left 
hip pain 
Fig. 2. Two permeative 
pheochromocytoma metastases in 
the proximal left femur of a 56- 
year-old man (patient 6) who 
presented with left thigh and right 
shoulder pain. He had a lesion 
with a similar appearance in the 
proximal right humerus 
Fig. 3. CT scan demonstrating an expansile mixed lytic and 
sclerotic pheochromocytoma metastasis involving the right pos- 
terior elements and posterior vertebral body at the level of 
T8 in a 30-year-old man (patient 5) who presented with back 
pain 
mocytoma,  the diagnosis should be considered be- 
cause bone biopsy in patients without adrenergic 
blockade may result in severe complications. Gen- 
eral anesthesia and tumor  manipulat ion may cause 
a sudden increase in circulating catecholamine lev- 
els, precipitating a hypertensive crisis or arrhyth- 
mia [4, 7]. Pheochromocytoma is a highly vascular 
lesion, and al though there are no reported in- 
stances of difficulty with hemostasis during biopsy 
of bone metastases from this tumor,  the potential 
for this complication exists. Massive blood loss, 
hypertensive episodes, and cardiac arrest have all 
occurred during resection of intra-abdominal 
pheochromocytomas [4, 7]. Hypertensive episodes 
occurred in two of the three patients in our series 
who underwent bone biopsy. 
When a patient presents with a destructive 
bone lesion from an unknown cause, we recom- 
mend taking a careful history, with particular at- 
tention to symptoms associated with hypercate- 
cholaminemia (including headache, dizziness, 
flushing, and palpitations), and performing a care- 
ful examination for the physical findings of 
pheochromocytoma (including hypertension, 
tachycardia, sweating, and pallor). All the patients 
in our series were either hypertensive at presenta- 
tion or had a history of hypertension. Three had 
a history of symptoms that were probably related 
to hypercatecholaminemia, but these were recog- 
nized only in retrospect. 
Further investigations prior to bone biopsy 
should include biochemical measurements such as 
serum and/or  urinary catecholamines. These stud- 
ies have relatively high sensitivity and specificity 
[1, 3, 7]. In addition, abdominal computed tomog- 
raphy and 13 I I .MIBG scintigraphy should be con- 
sidered. Iodine-131-MIBG scintigraphy is positive 
in the majority of pheochromocytomas,  both pri- 
mary and secondary [10, 15]. Ninety percent of 
primary pheochromocytomas are adrenal, and 
M.D. Lynn et al. : Pheochromocytoma presenting as musculoskeletal pain 555 
m o s t  o f  the  r e m a i n d e r  a r e  e x t r a - a d r e n a l  b u t  i n t r a -  
a b d o m i n a l  [2]. T h u s  a n e g a t i v e  a b d o m i n a l  C T  scan  
wil l  exc lude  a d i a g n o s i s  o f  m e t a s t a t i c  p h e o c h r o m o -  
c y t o m a  in the  m a j o r i t y  o f  cases .  B e c a u s e  c o n t r a s t  
m a t e r i a l  h a s  o c c a s i o n a l l y  i n d u c e d  h y p e r t e n s i v e  
cr ises  in u n b l o c k e d  p a t i e n t s  [14], a l p h a  a d r e n e r g i c  
b l o c k a d e  s h o u l d  be  i n s t i t u t e d  p r i o r  to  I V  c o n t r a s t  
a d m i n i s t r a t i o n  in  a n y  p a t i e n t  w i t h  s u s p e c t e d  
p h e o c h r o m o c y t o m a s .  
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